中文

金凯生科 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-25
ItemAmountY/Y
Revenue¥0.15B-16.0%
Gross profit¥0.06B
Operating income¥0.02B
Net income¥0.02B-64.9%
Gross margin42.3%Net margin 11.2%
Revenue Q/Q-2.3%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.09B57.7%
R&D¥0.01B5.3%
SG&A¥0.03B21.8%
Tax & other¥0.00B2.4%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

固高科技德福科技智信精密尚水智能港通医疗中远通陕西华达长华化学舜禹股份万邦医药上大股份儒竞科技

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies